Skip to main content
. 2021 Aug 13;22(4):1179. doi: 10.3892/etm.2021.10613

Figure 2.

Figure 2

Expression of SSTR5 in NETs. (A) Well-differentiated NET, G1. (B) SSTR5-positive staining, magnification x20. (C) Well-differentiated NET, G2 with microcalcifications. (D) SSTR5-positive staining, magnification x20. (E) Well-differentiated NET, G3. (F) Weak SSTR5-positive staining, magnification x40. (G) LCNEC. (H) Strong SSTR5-positive staining, x20 magnification. SSTR, somatostatin receptor; G, grade; NET, neuroendocrine tumor; LCNEC, large cell neuroendocrine carcinoma.